Apmonia Therapeutics
Created in 2019
Up & running (A)
Existing signals show a regular activitySocial networks
3,188Activities
Technologies
Entity types
Location
2 Esp. Roland Garros, 51100 Reims, France
Reims
France
Employees
Scale: 2-10
Estimated: 18
SIREN
849959390Engaged catalyst
37
0 0Added in Motherbase
2 years, 6 months ago
Value proposition
Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies.
Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Our innovative technological approach is to target tumors overexpressing matricellular protein thrombospondin-1 (TSP-1).
Our long-term vision is to develop personalized immunotherapy approaches combining a proprietary therapeutic peptide targeting TSP-1 (namely TAX2 peptide) and a companion diagnostic kit, which may enable patient stratification for TAX2 therapy eligibility based on the monitoring of circulating TSP-1.
immunologie and oncologieOriginal language
Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies.
Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Our innovative technological approach is to target tumors overexpressing matricellular protein thrombospondin-1 (TSP-1).
Our long-term vision is to develop personalized immunotherapy approaches combining a proprietary therapeutic peptide targeting TSP-1 (namely TAX2 peptide) and a companion diagnostic kit, which may enable patient stratification for TAX2 therapy eligibility based on the monitoring of circulating TSP-1.
Accueil - Apmonia therapeutics
https://apmonia-therapeutics.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Ministère des Affaires étrangères français | Other 11 Apr 2025 | | |
 Eurostat European Union, Environmental Services | Eurostat European Union, Environmental Services | Other 4 Apr 2025 | | |
 Groupe Caisse des Dépôts Finance, Government Administration | Groupe Caisse des Dépôts Finance, Government Administration | Other 11 Apr 2025 | | |
 Quest for health Startup accelerator & VC | Quest for health Startup accelerator & VC | Other 19 Nov 2024 | | |
 Quest for change Startup accelerator & VC | Quest for change Startup accelerator & VC | Other 19 Nov 2024 | | |
 Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 4 Feb 2025 | | |
 J.P. Morgan Bank | J.P. Morgan Bank | Other 1 Jan 2025 | | |
 Grand Est Développement, l'Agence régionale des transformations (Grand E-Nov+) Consulting, Business Consulting and Services | Grand Est Développement, l'Agence régionale des transformations (Grand E-Nov+) Consulting, Business Consulting and Services | Other 19 Nov 2024 | | |
 Région Grand Est National and local authorities, Government Administration | Région Grand Est National and local authorities, Government Administration | Other 19 Nov 2024 | | |
 Maddyness Media, Media Production | Maddyness Media, Media Production | Other 5 Oct 2024 | | |